Pollution and Epigenetics: A Hidden Driver of Diabetes

Uncovering How Environmental Chemicals May Influence Gene Expression and Increase Diabetes Risk

Diabetes: A Global Burden with Complex Causes

Diabetes mellitus (DM) is one of the most widespread metabolic diseases globally. Characterized by elevated blood glucose levels, it results from either a lack of insulin production (type 1 diabetes) or insulin resistance and inadequate secretion (type 2 diabetes). According to recent estimates, around 500 million people worldwide are affected by diabetes, and 1.5 million deaths are attributed to the disease each year.

Type 1 diabetes (T1DM) is an autoimmune disorder where the immune system mistakenly destroys insulin-producing beta cells in the pancreas. It accounts for about 10% of all diabetes cases, most commonly appearing in children and adolescents. In contrast, type 2 diabetes (T2DM) is far more prevalent, making up about 90% of global cases. It arises from a combination of insulin resistance and progressive beta-cell dysfunction.

While conventional risk factors such as genetics, diet, obesity, and physical inactivity are well established, they do not fully explain the rapidly rising prevalence of diabetes globally. This gap has led researchers to examine other potential contributors—including environmental exposures.

Beyond Lifestyle: The Role of Environmental Pollutants

Environmental chemicals are now being recognized as emerging risk factors in diabetes. These pollutants include particulate matter (PM), heavy metals like arsenic and lead, and persistent organic pollutants (POPs) such as dioxins and polychlorinated biphenyls (PCBs).

These substances are widespread in the air, water, and food. Once inside the body, they can disrupt normal metabolic function. A key mechanism through which this occurs is the activation of the aryl hydrocarbon receptor (AhR)—a transcription factor that regulates the expression of detoxifying enzymes, particularly those from the cytochrome P450 (CYP1) family.

Prolonged activation of the AhR/CYP1 pathway has been linked to oxidative stress, systemic inflammation, and impaired glucose metabolism—all hallmark features of diabetes.

A New Layer: Epigenetic Modifications

This review article focuses on the intersection of environmental exposure, AhR/CYP1 pathway activation, and epigenetics. Epigenetic modifications do not alter the DNA sequence itself but influence how genes are expressed. The three main mechanisms are:

• DNA methylation

• Histone modifications

• MicroRNA (miRNA) regulation

These processes are sensitive to environmental stimuli and play a crucial role in regulating insulin secretion, glucose uptake, and beta-cell function.

Mechanistic Insights

DNA Methylation

DNA methylation involves the addition of a methyl group to the DNA molecule, typically leading to gene silencing. The article discusses how environmental pollutants can induce DNA methylation changes that are linked to insulin resistance and altered glucose regulation.

For example, arsenic exposure was associated with reduced methylation of the SQSTM1 gene, a regulator of inflammation and metabolic processes. Similarly, particulate matter exposure was linked to methylation changes in LINE-1, a genomic element implicated in developmental programming. In prenatal settings, pollutants such as bisphenol A (BPA) were shown to affect the methylation of Igf2, a gene critical for beta-cell development.

These changes may persist long after exposure, influencing disease susceptibility throughout life.

Histone Modifications

Histones are proteins that help package DNA into chromatin. Modifications such as acetylation, methylation, and lactylation can change how tightly DNA is wrapped and thus how actively genes are transcribed.

This review highlights that pollutants like TCDD can lead to:

• Hyperacetylation of histones at key gene promoters (e.g., CYP1A1),

• Upregulation of HDAC7, linked to reduced insulin secretion,

• And emerging mechanisms like histone lactylation, which is associated with insulin resistance in obese individuals.

The connection between histone modification and AhR activation presents a novel explanation for how pollutants might drive beta-cell dysfunction and glucose intolerance.

MicroRNA Dysregulation

MicroRNAs (miRNAs) are small RNA molecules that regulate gene expression post-transcriptionally. Dysregulation of certain miRNAs has been linked to both type 1 and type 2 diabetes.

The article notes several important findings:

• miR-143 is associated with elevated blood glucose and lipid levels.

• miR-29 family members are implicated in insulin resistance across tissues.

• miR-375 is crucial for insulin secretion and is the most abundant miRNA in beta cells.

Notably, environmental pollutants such as diesel exhaust and particulate matter can increase the expression of miR-375. This miRNA was shown to suppress AhR expression, creating a potential feedback loop between environmental exposure and metabolic regulation.

The AhR/CYP1 Pathway as a Central Node

Across various in vivo, in vitro, and epidemiological studies discussed in the article, the AhR/CYP1 signaling pathway emerges as a central mechanism linking environmental toxins to metabolic dysfunction. The pathway influences gene expression not only through transcriptional control but also by triggering epigenetic changes.

For example, exposure to TCDD led to:

• Demethylation of the CYP1A1 promoter,

• Upregulation of genes involved in glucose intolerance,

• And modifications to histones at specific gene loci.

In animal models lacking AhR, protective effects were observed—such as improved insulin sensitivity and reduced weight gain—further supporting the hypothesis that this pathway plays a critical role in diabetes development.

A Call for Deeper Exploration

Despite these advances, the authors emphasize that more research is needed. Particularly, the crosstalk between epigenetic changes and AhR/CYP1 signaling in the context of insulin resistance remains poorly understood.

Understanding these interactions could:

• Improve early detection through biomarkers,

• Inform new therapeutic strategies targeting epigenetic enzymes or receptors like AhR,

• Support public health policies aimed at reducing environmental pollutant exposure as a diabetes prevention strategy.

Conclusion

This review article sheds light on a growing and underexplored area of diabetes research: how environmental pollutants may reprogram gene expression through epigenetics, increasing susceptibility to diabetes. The activation of the AhR/CYP1 pathway serves as a mechanistic link, providing a new lens through which to understand the disease beyond traditional risk factors.

While much remains to be investigated, this work lays the foundation for a more integrated understanding of diabetes—one that considers the environment, gene expression, and molecular signaling as part of a broader disease framework.

“Understanding these interactions not only advances our knowledge of DM etiology but also highlights novel molecular targets for preventive and therapeutic strategies.”

 

The translation of the preceding English text in Arabic: